NONSEGMENTAL VITILIGO
Clinical trials for NONSEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NONSEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NONSEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for vitiligo in major trial
Disease control OngoingThis study tests an experimental drug called povorcitinib in 450 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can safely bring back skin color, especially on the face, over 52 weeks. Participants will receive…
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 06:47 UTC
-
New pill could help vitiligo patients regain skin color
Disease control OngoingThis study tests a daily pill called povorcitinib for adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The goal is to see if it can safely bring back color, especially on the face. About 467 participants will take either the drug or a placebo …
Matched conditions: NONSEGMENTAL VITILIGO
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 15, 2026 11:55 UTC